Class 2 medicines recall for mitoxantrone
The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a class 2 medicines recall (action within 48 hours) for mitoxantrone 2mg/ml concentrate for solution for infusion, manufactured by Hospira UK Limited. This is because of a number of confirmed out of specification test results obtained during stability studies. Pharmacists should quarantine any remaining stock and Hospira will contact customers who may have received the impacted batches to arrange collection via their primary wholesaler, Movianto. Further information is available on the MHRA website or from Hospira UK on 0800 0287304.
Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2014.20067269
Recommended from Pharmaceutical Press